Back to search

Article

A New Venue of TNF Targeting

2018-04-02

Abstract excerpt

The first FDA-approved drugs were small, chemically-manufactured and highly active molecules with possible off-target effects. After this first successful wave of small drugs, biotechnology allowed the development of protein-based medicines such as antibodies. Conventional antibodies bind a specific protein and are becoming increasingly important in the therapeutic landscape. A very prominent class of biologicals...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
57e3dbae-26ef-5fb4-acb1-cdad7514873f
DOI
10.20944/preprints201804.0015.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A New Venue of TNF TargetingDOI 10.20944/preprints201804.0015.v1
Select a neighboring publication to make it the new centre.